Nintedanib 00781-2495
Product NDC
00781-2495- Manufacturer
- Sandoz Inc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 2, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA216915
Need to source Nintedanib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nintedanib Esylate | 150 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Packaging Options(1)
60 CAPSULE in 1 BOTTLE (0781-2495-60)